Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Proteon initiates second phase III study of vonapanitase

Aug. 17, 2015

Daiichi Sankyo discloses compounds for hyperphosphatemia

Aug. 13, 2015

Relypsa signs new patiromer agreements

Aug. 12, 2015

FDA accepts NDA for ZS-9 in hyperkalemia

July 30, 2015

Phase III extension studies show long-term benefit of NX-1207 in BPH

July 29, 2015

EMA committee recommends approval of Fexeric

July 27, 2015

Vidasym's phosphate binder VS-505 enters phase I/II trial

July 23, 2015

Gilead patents MAP3K5 inhibitors

July 20, 2015

ErepoXen increases hemoglobin levels to therapeutic range in phase II trial

July 16, 2015

Merck & Co. divulges ROMK channel blockers

July 15, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...